Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review

Background: Moyamoya syndrome, a progressive, idiopathic stenosis of the internal carotid arteries, results in increased risk for both ischemic and hemorrhagic strokes. Revascularization procedures have been shown in small studies to be both safe and efficacious for these patients; however, randomiz...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2020
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23494
Acceso en línea:
https://doi.org/10.1016/j.wneu.2019.11.137
https://repository.urosario.edu.co/handle/10336/23494
Palabra clave:
Blood transfusion
Cerebral revascularization
Cerebrovascular accident
Complication
Conservative treatment
Human
Moyamoya disease
Postoperative complication
Procedures
Sickle cell anemia
Transient ischemic attack
Treatment outcome
Blood transfusion
Cerebral revascularization
Conservative treatment
Humans
Moyamoya disease
Postoperative complications
Stroke
Treatment outcome
Chronic transfusion therapy
Moyamoya syndrome
Revascularization
Sickle cell disease
Stroke
transient
sickle cell
Anemia
Ischemic attack
Rights
License
Abierto (Texto Completo)
id EDOCUR2_be662e938767ba004d5b03818bec31b4
oai_identifier_str oai:repository.urosario.edu.co:10336/23494
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 433b07f9-ad55-4d58-90f7-0859b45297ca-10e4aa459-8218-4c3a-adcd-2d74b9c67ce2-16f601d40-dd74-477e-b277-525ae79e9fd8-14ffc4a5c-959c-4de8-8abf-426ca4f34fa7-11536cd39-e202-4e47-871e-dbd40e3f9a31-14ffc4a5c-959c-4de8-8abf-426ca4f34fa7-12020-05-26T00:02:31Z2020-05-26T00:02:31Z2020Background: Moyamoya syndrome, a progressive, idiopathic stenosis of the internal carotid arteries, results in increased risk for both ischemic and hemorrhagic strokes. Revascularization procedures have been shown in small studies to be both safe and efficacious for these patients; however, randomized controlled trials are lacking. The goal of this systematic review is to organize the literature evaluating surgical intervention versus conservative medical management. Methods: A systematic review was performed including studies with 3 or more participants with moyamoya syndrome in the setting of sickle cell disease and a measured outcome after either medical or surgical intervention. Relevant studies were identified using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria and a set of predetermined key words. Results: Sixty-one articles were identified with 6 articles ultimately included in this review (N = 122). Of the patients, 73 (59.8%) were revascularized surgically (all indirect procedures), whereas 49 (40.2%) remained on chronic transfusion therapy. Of the patients that underwent indirect revascularization surgery, a total of 1 perioperative (1.4%) and 4 postoperative strokes (5.5%) were reported over 44 months (1 stroke per 53.3 patient-years). In comparison, an average of 46.5% of patients who were receiving chronic transfusions had major events (stroke or transient ischemic attack) while undergoing therapy (1 stroke per 13.65 patient-years, P = 0.00215). Conclusions: We present a large systematic review of the literature regarding outcomes of surgical and medical management for patients with moyamoya syndrome and sickle cell disease. The findings redemonstrate the efficacy and safety of surgical revascularization, and advocate for earlier discussion around surgical intervention. © 2019 Elsevier Inc.application/pdfhttps://doi.org/10.1016/j.wneu.2019.11.13718788750https://repository.urosario.edu.co/handle/10336/23494engElsevier Inc.170165World NeurosurgeryVol. 135World Neurosurgery, ISSN:18788750, Vol.135,(2020); pp. 165-170https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077447634&doi=10.1016%2fj.wneu.2019.11.137&partnerID=40&md5=ada020c7b1a16f994f3aeb692cc5fe47Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURBlood transfusionCerebral revascularizationCerebrovascular accidentComplicationConservative treatmentHumanMoyamoya diseasePostoperative complicationProceduresSickle cell anemiaTransient ischemic attackTreatment outcomeBlood transfusionCerebral revascularizationConservative treatmentHumansMoyamoya diseasePostoperative complicationsStrokeTreatment outcomeChronic transfusion therapyMoyamoya syndromeRevascularizationSickle cell diseaseStroketransientsickle cellAnemiaIschemic attackOutcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic ReviewarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Newman, SarahBoulter, Jason H.Malcolm, James G.Pradilla, GustavoPradilla, IvanPradilla, Gustavo10336/23494oai:repository.urosario.edu.co:10336/234942022-05-02 07:37:21.016861https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review
title Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review
spellingShingle Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review
Blood transfusion
Cerebral revascularization
Cerebrovascular accident
Complication
Conservative treatment
Human
Moyamoya disease
Postoperative complication
Procedures
Sickle cell anemia
Transient ischemic attack
Treatment outcome
Blood transfusion
Cerebral revascularization
Conservative treatment
Humans
Moyamoya disease
Postoperative complications
Stroke
Treatment outcome
Chronic transfusion therapy
Moyamoya syndrome
Revascularization
Sickle cell disease
Stroke
transient
sickle cell
Anemia
Ischemic attack
title_short Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review
title_full Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review
title_fullStr Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review
title_full_unstemmed Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review
title_sort Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review
dc.subject.keyword.spa.fl_str_mv Blood transfusion
Cerebral revascularization
Cerebrovascular accident
Complication
Conservative treatment
Human
Moyamoya disease
Postoperative complication
Procedures
Sickle cell anemia
Transient ischemic attack
Treatment outcome
Blood transfusion
Cerebral revascularization
Conservative treatment
Humans
Moyamoya disease
Postoperative complications
Stroke
Treatment outcome
Chronic transfusion therapy
Moyamoya syndrome
Revascularization
Sickle cell disease
Stroke
topic Blood transfusion
Cerebral revascularization
Cerebrovascular accident
Complication
Conservative treatment
Human
Moyamoya disease
Postoperative complication
Procedures
Sickle cell anemia
Transient ischemic attack
Treatment outcome
Blood transfusion
Cerebral revascularization
Conservative treatment
Humans
Moyamoya disease
Postoperative complications
Stroke
Treatment outcome
Chronic transfusion therapy
Moyamoya syndrome
Revascularization
Sickle cell disease
Stroke
transient
sickle cell
Anemia
Ischemic attack
dc.subject.keyword.eng.fl_str_mv transient
sickle cell
Anemia
Ischemic attack
description Background: Moyamoya syndrome, a progressive, idiopathic stenosis of the internal carotid arteries, results in increased risk for both ischemic and hemorrhagic strokes. Revascularization procedures have been shown in small studies to be both safe and efficacious for these patients; however, randomized controlled trials are lacking. The goal of this systematic review is to organize the literature evaluating surgical intervention versus conservative medical management. Methods: A systematic review was performed including studies with 3 or more participants with moyamoya syndrome in the setting of sickle cell disease and a measured outcome after either medical or surgical intervention. Relevant studies were identified using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria and a set of predetermined key words. Results: Sixty-one articles were identified with 6 articles ultimately included in this review (N = 122). Of the patients, 73 (59.8%) were revascularized surgically (all indirect procedures), whereas 49 (40.2%) remained on chronic transfusion therapy. Of the patients that underwent indirect revascularization surgery, a total of 1 perioperative (1.4%) and 4 postoperative strokes (5.5%) were reported over 44 months (1 stroke per 53.3 patient-years). In comparison, an average of 46.5% of patients who were receiving chronic transfusions had major events (stroke or transient ischemic attack) while undergoing therapy (1 stroke per 13.65 patient-years, P = 0.00215). Conclusions: We present a large systematic review of the literature regarding outcomes of surgical and medical management for patients with moyamoya syndrome and sickle cell disease. The findings redemonstrate the efficacy and safety of surgical revascularization, and advocate for earlier discussion around surgical intervention. © 2019 Elsevier Inc.
publishDate 2020
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:02:31Z
dc.date.available.none.fl_str_mv 2020-05-26T00:02:31Z
dc.date.created.spa.fl_str_mv 2020
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1016/j.wneu.2019.11.137
dc.identifier.issn.none.fl_str_mv 18788750
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/23494
url https://doi.org/10.1016/j.wneu.2019.11.137
https://repository.urosario.edu.co/handle/10336/23494
identifier_str_mv 18788750
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 170
dc.relation.citationStartPage.none.fl_str_mv 165
dc.relation.citationTitle.none.fl_str_mv World Neurosurgery
dc.relation.citationVolume.none.fl_str_mv Vol. 135
dc.relation.ispartof.spa.fl_str_mv World Neurosurgery, ISSN:18788750, Vol.135,(2020); pp. 165-170
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077447634&doi=10.1016%2fj.wneu.2019.11.137&partnerID=40&md5=ada020c7b1a16f994f3aeb692cc5fe47
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Elsevier Inc.
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1808391057064329216